July 28: Adaptimmune's Asset Deal; UroGen's Bladder Cancer Data; Shanton on Fast Track

VIEW IN BROWSER

Co-Producer

july 28, 2025

Covering Life Sciences Drugs, Diagnostics, Devices, Digital Health

* may need subscription to view

Press Releases

AstraZeneca: Imfinzi (Durvalumab) Granted Priority Review and Breakthrough Therapy Designation in the US for Patients With Resectable Early-Stage Gastric and Gastroesophageal Junction Cancers More
Children's Hospital of Philadelphia: Researchers Analyze Best Methods to Minimize Risk of Pediatric Vehicular Heatstroke More
Shanton: Receives Fast Track Designation From US FDA for Refractory Gout Program More
UroGen: Publication of Phase 3b Study Results Demonstrating the Feasibility of Home Instillation of ZUSDURI for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer in Reviews in Urology More

Amplify your impact. Maximize your investment. Brought to you by Big4Bio and PR Newswire

Financial News

Investment Banking Advisory to the Life Science Industry

Learn More →

Adaptimmune: Entry Into Definitive Agreement for Sale of TECELRA, lete-cel, afami-cel and uza-cel Cell Therapies to US WorldMeds More
IMUNON: Stock Dividend Boosting Shareholder Value More

Media/Misc Coverage

Spend your summer with LSPA – from leadership panels to networking, educational courses to our biggest partnering event, click here to view our calendar of events!

Learn More →

BiotechTV: AI X Bio Summit: Proscia CEO David West Describes How AI in Pathology Is Not Just Helping Pathologists Find Disease, but Can Also Help Get the Right Drug to the Right Patient Video
More on BMS Naming AstraZeneca's Cristian Massacesi as New Chief Medical Officer More More*
Subscribe to LifeSci Startup for Updates on US Startups More

Companies

DISCOVER COMPANIES

Big4Bio: Philadelphia Life Science Company Directory

Locate a specific company or explore new companies in life science.

Explore our Company Directory

Provided courtesy of

Feature your company

Apply to have your company showcased by Big4Bio

Apply Today

Career Center

Premier Executive Search and Talent Advisory Firm Slone Partners Launches Fractional Talent Service to Deliver On-Demand Leaders and Specialists

Learn More →

Feature: CEO's Perspective: The Power of Pivoting More
ICYMI: What Defines Great Leadership? More
ICYMI: The Future of Hiring: How Fractional Talent is Reshaping The Workforce More
ICYMI:Beyond Cautious Optimism: Why a Hybrid Talent Model is the Future for Life Sciences & Healthcare More

Event Center

Note: Events may be in any Big4Bio region or virtual

15th Annual DPHARM, Sept 16-17

Learn More →

WIB-Greater Boston: New & Interested Member Virtual Information Session Aug 11
Immuno-Oncology Summit 2025 Aug 11-13
Next Generation DX Summit Aug 18-20
The Bioprocessing Summit 2025 Aug 18-21
Biotech Networks Speed Networking Philadelphia Aug 26
Charles River Biotech Symposium Sept 8-10
Philly Builds Bio+ 4th Annual Symposium for Life Science Innovation and Development Sept 9
CRAACO: Clinical Research as a Care Option Sept 15
Partnerships with Sites Sept 15
15th Annual DPHARM Sept 16-17
RESI Boston 2025 Sept 17
Discovery On Target Sept 22-25
Life Sciences Future Sept 25-26

SEE FULL EVENT SCHEDULE AT THE BIOCALENDAR

Philadelphia Sponsors

PREMIER

Spotlights Get Featured Company Directory News Contact Subscribe

You are receiving this email because you signed up for one of our newsletters at Big4Bio.com, signed up at one of our partner or sponsor events, or given as a gift subscription by your firm or organization. Unsubscribe